A V-shaped ligand 1,3-bis(1-methylbenzimidazol-2-yl)-2-oxapropane and its Cu(II) complex: Synthesis, crystal structure, antioxidation and DNA-binding properties

Larsen, 1986, Bis-benzimidazole-appended binucleating porphyrin ligands: synthesis, characterization, and X-ray structure, J. Am. Chem. Soc., 108, 6950, 10.1021/ja00282a020 Michael, 1997, Effect of a chemical modification on the hydrated adenosine intermediate produced by adenosine deaminase and a model reaction for a potential mechanism of action of 5-aminoimidazole ribonucleotide carboxylase, J. Med. Chem., 40, 3336, 10.1021/jm970301s Szyszka, 1995, Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK-I and CK-II from Saccharomyces cerevisiae and other sources, Biochem. Biophys. Res. Commun., 208, 418, 10.1006/bbrc.1995.1354 Pilch, 1996, Characterizing the DNA binding modes of a topoisomerase I-poisoning terbenzimidazole: evidence for both intercalative and minor groove binding properties, Drug Des. Discov., 13, 115 Willis, 2010, Triple recognition of B-DNA by a neomycin–hoechst 33258–pyrene conjugate, Biochemistry, 49, 452, 10.1021/bi9016796 Clarke, 2003, Ruthenium metallopharmaceuticals, Coord. Chem. Rev., 236, 209, 10.1016/S0010-8545(02)00312-0 Hartinger, 2006, From bench to bedside – preclinical and early clinical development of the anticancer agent imidazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A), J. Inorg. Biochem., 100, 891, 10.1016/j.jinorgbio.2006.02.013 Sathyaraj, 2010, Synthesis, characterization and DNA binding studies of new ruthenium(II)bisterpyridine complexes, Eur. J. Med. Chem., 45, 284, 10.1016/j.ejmech.2009.10.008 Erkkila, 1999, Recognition and reaction of metallointercalators with DNA, Chem. Rev., 99, 2777, 10.1021/cr9804341 Metcalfe, 2003, Kinetically inert transition metal complexes that reversibly bind to DNA, Chem. Soc. Rev., 32, 215, 10.1039/b201945k Xiong, 1999, Synthesis, DNA-binding and DNA-mediated luminescence quenching of Ru(II) polypyridine complexes, Coord. Chem. Rev., 185, 711, 10.1016/S0010-8545(99)00019-3 Blasius, 2004, photoadducts of metallic compounds with nucleic acids – role played by the photoelectron transfer process and by the TAP and HAT ligands in the RuII complexes, Eur. J. Inorg. Chem., 2004, 3971, 10.1002/ejic.200400489 Uma, 2005, Oxidative DNA cleavage mediated by a new copper (II) terpyridine complex: crystal structure and DNA binding studies, J. Inorg. Biochem., 99, 2299, 10.1016/j.jinorgbio.2005.08.011 Zhou, 2006, Crystal structure and DNA-binding studies of a new Cu(II) complex involving benzimidazole, Inorg. Chim. Acta, 359, 1200, 10.1016/j.ica.2005.11.003 Li, 2007, DNA-binding and cleavage studies of novel binuclear copper(II) complex with 1,1′-dimethyl-2,2′-biimidazole ligand, J. Inorg. Biochem., 101, 283, 10.1016/j.jinorgbio.2006.10.004 Dong, 2011, Synthesis, crystal structure and DNA-binding properties of a new copper(II) complex with l-valine Schiff base and 1,10-phenanthroline, J. Mol. Struct., 986, 57, 10.1016/j.molstruc.2010.11.036 Ames, 1993, Oxidants, antioxidants, and the degenerative diseases of aging, Proc. Natl. Acad. Sci. USA, 90, 7915, 10.1073/pnas.90.17.7915 Horton, 1987, Lipid peroxidation and mechanisms of toxicity, Crit. Rev. Toxicol., 18, 27, 10.3109/10408448709089856 Wang, 2006, Synthesis, characterization and the antioxidative activity of copper(II), zinc(II) and nickel(II) complexes with naringenin, Transit. Met. Chem., 31, 470, 10.1007/s11243-006-0015-3 Wu, 2009, Synthesis, crystal structure and electrochemical properties of the copper(II) complex with 1,3-bis(benzimidazol-2-yl)-2-oxopropane, Synth. React. Inorg. Met. Org. Nano. Met. Chem., 39, 406, 10.1080/15533170903129802 Wu, 2010, Copper(II) supramolecular complex: synthesis, crystal structure, and electrochemical property, Z. Anorg. Allg. Chem., 636, 1397, 10.1002/zaac.200900454 Chen, 2011, 1,3-Bis(1H-benzimidazol-2-yl)-2-oxapropane, Acta Cryst., E65, o948 Wu, 2011, 1,3-Bis(1-benzyl-1H-benzimidazol-2-yl)-2-oxapropane, Acta Cryst., E65, o1014 Satyanarayana, 1993, Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding, Biochemistry, 32, 2573, 10.1021/bi00061a015 Reichmann, 1954, A further examination of the molecular weight and size of desoxypentose nucleic acid, J. Am. Chem. Soc., 76, 3047, 10.1021/ja01640a067 Kou, 2011, 1,3-Bis(1-methyl-1H-benzimidazol-2-yl)-2-oxapropane, Acta Cryst., E67, o1439 Bruker, APEX2 and SAINT, Bruker Axs, Inc., Madison, WI, USA, 2007. G.M. Sheldrick, SHELXTL, Siemens Analytical X-ray Instruments, Inc., Madison, WI, USA, 1996. Pyle, 1989, Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA, J. Am. Chem. Soc., 111, 3051, 10.1021/ja00190a046 Wolf, 1987, Biochemistry, 26, 6392, 10.1021/bi00394a013 Baguley, 1984, Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA, Biochemistry, 23, 937, 10.1021/bi00300a022 Lakowicz, 1973, Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules, Biochemistry, 12, 4161, 10.1021/bi00745a020 Tan, 2008, Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes, J. Inorg. Biochem., 102, 1644, 10.1016/j.jinorgbio.2008.03.005 Winterbourn, 1981, Hydroxyl radical production in body fluids. Roles of metal ions, ascorbate and superoxide, Biochem. J., 198, 125, 10.1042/bj1980125 Winterbourn, 1979, Comparison of superoxide with other reducing agents in the biological production of hydroxyl radicals, Biochem. J., 182, 625, 10.1042/bj1820625 Guo, 2005, The synthesis and antioxidant activity of the Schiff bases of chitosan and carboxymethyl chitosan, Bioorg. Med. Chem. Lett., 15, 4600, 10.1016/j.bmcl.2005.06.095 Beauchamp, 1971, Superoxide dismutase: improved assays and an assay applicable to acrylamide gels, Anal. Biochem., 44, 276, 10.1016/0003-2697(71)90370-8 Luo, 1993, A study on the structure and properties of a new model compound of Cu(II)–Zn(II)–superoxide dismutase, J. Inorg. Biochem., 51, 655, 10.1016/0162-0134(93)85037-9 Geary, 1971, The use of conductivity measurements in organic solvents for the characterisation of coordination compounds, Coord. Chem. Rev., 7, 81, 10.1016/S0010-8545(00)80009-0 McKee, 1985, Further insight into magnetostructural correlations in binuclear copper(II) species related to methemocyanin: X-ray crystal structure of 1,2-mu-nitrito complex, Inorg. Chem., 24, 2914, 10.1021/ic00213a009 Thompson, 1977, Cobalt(II) and zinc(II) complexes of the ‘tripod’ ligand tris(2-benzimidazylmethyl)amine. Some five-coordinate derivatives and some with mixed stereochemistries, Can. J. Chem., 55, 878, 10.1139/v77-122 Addison, 1981, Copper complexes of the “tripod” ligand tris(2-benzimidazolylmethyl)amine: five- and six-coordinate copper(II) derivatives and some copper(I) derivatives, Inorg. Chem., 20, 103, 10.1021/ic50215a024 Koppenol, 1986, Catalysis of superoxide dismutation by manganese aminopolycarboxylate complexes, Arch. Biochem. Biophys., 251, 594, 10.1016/0003-9861(86)90368-1 Wu, 2010, A V-shaped ligand 2,6-bis(2-benzimidazolyl)pyridine and its picrate Mn(II) complex: synthesis, crystal structure and DNA-binding properties, Eur. J. Med. Chem., 45, 5324, 10.1016/j.ejmech.2010.08.055 Zhang, 2004, DNA-binding and photoactivated enantiospecific cleavage of chiral polypyridyl ruthenium(II) complexes, J. Inorg. Biochem., 98, 1405, 10.1016/j.jinorgbio.2004.05.007 Indumathy, 2010, Biimidazole containing cobalt(III) mixed ligand complexes: crystal structure and photonuclease activity, Dalton Trans., 39, 2087, 10.1039/b913464f Lepecq, 1967, A fluorescent complex between ethidium bromide and nucleic acids: physical–chemical characterization, J. Mol. Biol., 27, 87, 10.1016/0022-2836(67)90353-1 Zhou, 2006, Synthesis, crystal structure and DNA binding studies of Zn(II) complex with 1,3-bis(benzimidazol-2-yl)-2-oxapropane, Acta Chim. Sin., 64, 793 Satyanarayana, 1992, Neither DELTA-nor LAMBDA-tris(phenanthroline)ruthenium(II) binds to DNA by classical intercalation, Biochemistry, 31, 9319, 10.1021/bi00154a001 Satyanarayana, 1993, Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding, Biochemistry, 32, 2573, 10.1021/bi00061a015 Li, 2008, Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth(III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand, Eur. J. Med. Chem., 43, 1688, 10.1016/j.ejmech.2007.10.006 Schepetkin, 2006, Decomposition of reactive oxygen species by copper(II) bis(1-pyrazolyl)methane complexes, J. Biol. Inorg. Chem., 11, 499, 10.1007/s00775-006-0101-1 Patel, 2010, SOD mimic activity, DNA binding and in-vitro antibacterial studies of drug based copper(II) complexes, Inorg. Chem. Commun., 13, 618, 10.1016/j.inoche.2010.03.001 Weder, 2002, Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized, Coord. Chem. Rev., 232, 95, 10.1016/S0010-8545(02)00086-3 Suksrichavalit, 2008, Copper complexes of nicotinic–aromatic carboxylic acids as superoxide dismutase mimetics, Molecules, 13, 3040, 10.3390/molecules13123040 Belichi-Ferrari, 1999, Synthesis, structural characterization and biological activity of helicin thiosemicarbazone monohydrate and a copper(II) complex of salicylaldehyde thiosemicarbazone, Inorg. Chim. Acta, 286, 134, 10.1016/S0020-1693(98)00383-1 Devereux, 2007, J. Inorg. Biohem., 101, 881, 10.1016/j.jinorgbio.2007.02.002